Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians

BACKGROUND AND AIMS: In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario. METHODS: PubMed and Google Scholar search engines were searched using the key terms ‘telem...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Amerta, Gupta, Ritesh, Misra, Anoop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of Diabetes India. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129346/
https://www.ncbi.nlm.nih.gov/pubmed/32283497
http://dx.doi.org/10.1016/j.dsx.2020.04.001
Descripción
Sumario:BACKGROUND AND AIMS: In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario. METHODS: PubMed and Google Scholar search engines were searched using the key terms ‘telemedicine’, ‘diabetes’, ‘COVID-19 up to 31(st) March 2020. In addition, existing guidelines including those by Ministry of Health and Family Welfare (MOHFW), Government of India, were accessed. RESULTS: We discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations. CONCLUSIONS: Telemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required.

Ejemplares similares